medigraphic.com
ISSN 1561-3119 (Electronic)

2022, Number 1

<< Back Next >>

Rev Cubana Pediatr 2022; 94 (1)

Cushing's syndrome due to adrenocortical carcinoma in a five-month-old infant

Casanovas FJ, Hernández-García F, García SJ, Valdés BER

Language: Spanish
References: 19
Page: 1-14
PDF size: 667.82 Kb.


ABSTRACT

Introduction: The adrenal causes of Cushing's syndrome such as carcinoma are the common etiologies in the child, although their incidence is low.
Objective: Describe the diagnostic and therapeutic procedures followed in the case of a five-month-old infant with Cushing's syndrome as a result of adrenocortical carcinoma.
Case presentation: Five-month-old female infant consulted due to excessive weight gain from the second month of birth despite not eating properly, in addition to presenting a stunted growth. Centripetal and facial plethora obesity, slight facial erythema and livedo reticularis, blood pressure of 130/80 mmHg (>95 percentile) were found. She had agenesis of labia minora, without axillary or pubic hair. In the study of adrenal function, elevated plasma cortisol levels were found. Abdominal CT scan showed hyperdense image compatible with adrenal tumor. Cushing's syndrome of adrenal etiology was diagnosed. Unilateral adrenalectomy was performed and a sample was taken for postoperative biopsy and the diagnosis of adrenocortical carcinoma was made. The patient presented an unfavorable evolution and she finally died as a result of a multi-organ failure a month after the surgery.
Conclusions: Given the clinical suspicion of Cushing's syndrome in the infant, the pertinent hormonal determinations were made and the etiology was specified by imaging tests, confirmed by post-surgical biopsy. Surgery is the most appropriate therapy for a patient with Cushing's syndrome with an adrenal tumor cause, although these patients usually have a bad prognosis.


REFERENCES

  1. Feelders RA, Newell-Price J, Pivonello R, Nieman LK, Hofland LJ, Lacroix A. Advances in the medical treatment of Cushing's syndrome. Lancet Diabetes Endocrinol. 2018;7(4):300-12. DOI: http://dx.doi.org/10.1016/S2213-8587(18)30155-4.

  2. Lodish MB, Keil MF, Stratakis CA. Cushing Syndrome in Pediatrics. Endocrinol Metab Clin North Am. 2018;47(2):451-62. DOI: http://dx.doi.org/10.1016/j.ecl.2018.02.008.

  3. Stratakis CA. An update on Cushing syndrome in pediatrics. Ann Endocrinol (Paris). 2018;79(3):125-131. DOI: https://doi.org/10.1016/j.ando.2018.03.010

  4. Wengander S, Trimpou P, Papakokkinou E, Ragnarsson O. The incidence of endogenous Cushing's syndrome in the modern era. Clin Endocrinol (Oxf). 2019;91(2):263-70. DOI: https://doi.org/10.1111/cen.14014.

  5. Broder MS, Neary MP, Chang E, Cherepanov D, Ludlam WH. Incidence of Cushing's syndrome and Cushing's disease in commercially-insured patients <65 years old in the United States. Pituitary. 2015;18(3):283-9. DOI: https://doi.org/10.1007/s11102-014-0569-6

  6. Ferrigno R, Hasenmajer V, Caiulo S, Minnetti M, Mazzotta P, Storr HL, et al. Paediatric Cushing's disease: Epidemiology, pathogenesis, clinical management and outcome. Rev Endocr Metab Disord. 2021. DOI: https://doi.org/10.1007/s11154-021-09626-4. Epub: 30 January 2021.

  7. Sharma ST, Nieman LK, Feelders RA. Cushing's syndrome: epidemiology and developments in disease management. Clin Epidemiol. 2015;7:281-93. DOI: https://doi.org/10.2147/CLEP.S44336

  8. Michalkiewicz E, Sandrini R, Figueiredo B, Miranda EC, Caran E, Oliveira-Filho AG, et al. Clinical and outcome characteristics of children with adrenocortical tumors: a report from the International Pediatric Adrenocortical Tumor Registry. J Clin Oncol. 2004;22(5):838-45. DOI: https://doi.org/10.1200/JCO.2004.08.085

  9. Kerkhofs TM, Ettaieb MH, Verhoeven RH, Kaspers GJ, Tissing WJ, Loeffen J, et al. Adrenocortical carcinoma in children: first population-based clinicopathological study with long-term follow-up. Oncol Rep. 2014;32(6):2836-44. DOI: https://doi.org/10.3892/or.2014.3506

  10. McAteer JP, Huaco JA, Gow KW. Predictors of survival in pediatric adrenocortical carcinoma: a Surveillance, Epidemiology, and End Results (SEER) program study. J Pediatr Surg. 2013;48(5):1025-31. DOI: https://doi.org/10.1016/j.jpedsurg.2013.02.017

  11. Ebbehoj A, Li D, Kaur RJ, Zhang C, Singh S, Li T, et al. Epidemiology of adrenal tumours in Olmsted County, Minnesota, USA: a population-based cohort study. Lancet Diabetes Endocrinol. 2020;8(11):894-902. DOI: https://doi.org/10.1016/S2213-8587(20)30314-4

  12. Chatterjee G, DasGupta S, Mukherjee G, Sengupta M, Roy P, Arun I, et al. Usefulness of Wieneke criteria in assessing morphologic characteristics of adrenocortical tumors in children. Pediatr Surg Int. 2015;31(6):563-71. DOI: https://doi.org/10.1007/s00383-015-3708-x

  13. Sandrini R, Ribeiro RC, DeLacerda L. Childhood adrenocortical tumors. J Clin Endocrinol Metab. 1997;82(7):2027-31. DOI: https://doi.org/10.1210/jcem.82.7.4057.

  14. Gupta N, Rivera M, Novotny P, Rodriguez V, Bancos I, Lteif A. Adrenocortical Carcinoma in Children: A Clinicopathological Analysis of 41 Patients at the Mayo Clinic from 1950 to 2017. Horm Res Paediatr. 2018;90(1):8-18. DOI: https://doi.org/10.1159/000488855

  15. Batista DL, Riar J, Keil M, Stratakis CA. Diagnostic tests for children who are referred for the investigation of Cushing syndrome. Pediatrics. 2007;120(3):e575-86. DOI: https://doi.org/10.1542/peds.2006-2402

  16. Fassnacht M, Johanssen S, Quinkler M, Bucsky P, Willenberg HS, Beuschlein F, et al. German Adrenocortical Carcinoma Registry Group; European Network for the Study of Adrenal Tumors. Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a Revised TNM Classification. Cancer. 2009;115(2):243-50. DOI: https://doi.org/10.1002/cncr.24030

  17. Rodriguez-Galindo C, Pappo AS, Krailo MD, Pashankar F, Monteiro Caran EM, Hicks J, et al. Treatment of childhood adrenocortical carcinoma (ACC) with surgery plus retroperitoneal lymph node dissection (RPLND) and multiagent chemotherapy: Results of the Children's Oncology Group ARAR0332 protocol. J Clin Oncol. 2016;34(15 Suppl):10515-10515. DOI: https://doi.org/10.1200/JCO.2016.34.15_suppl.10515

  18. Mizdrak M, Tičinović Kurir T, Božić J. The Role of Biomarkers in Adrenocortical Carcinoma: A Review of Current Evidence and Future Perspectives. Biomedicines. 2021;9(2):174. DOI: https://doi.org/10.3390/biomedicines9020174

  19. Gulack BC, Rialon KL, Englum BR, Kim J, Talbot LJ, Adibe OO, et al. Factors associated with survival in pediatric adrenocortical carcinoma: An analysis of the National Cancer Data Base (NCDB). J Pediatr Surg. 2016;51(1):172-7. DOI: https://doi.org/10.1016/j.jpedsurg.2015.10.039




2020     |     www.medigraphic.com